Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06776939

Physiological Effect High-flow Tracheal Oxygen on Viscosity of Airway Mucus and Respiratory Effort in Patients Weaning from Invasive Mechanical Ventilation

Led by Henrik Endeman · Updated on 2025-01-15

20

Participants Needed

1

Research Sites

77 weeks

Total Duration

On this page

Sponsors

H

Henrik Endeman

Lead Sponsor

F

Fisher and Paykel Healthcare

Collaborating Sponsor

AI-Summary

What this Trial Is About

Rationale: Tracheostomized patients weaning from mechanical ventilation are at risk for dryness of airway mucosa and sputum accumulation during disconnection from mechanical ventilation. High-flow tracheal oxygen (HFTO) is being used as supportive therapy during disconnection sessions in tracheostomized patients weaning from invasive mechanical ventilation (IMV) to limit dryness while maintaining oxygenation. We recently summarized the studies comparing physiological effects HFTO as compared to other interfaces, collectively referred to as conventional oxygen therapy (COT), in a systematic review and identified areas of lacking knowledge: effect on sputum viscoelasticity, respiratory effort early in the weaning process and dyspnea sensation. We hypothesize that HFTO, compared to COT, decreases viscoelasticity of the sputum and provides respiratory support during weaning. This may improve weaning by facilitating clearance of airway mucus, preventing respiratory failure, and providing comfort by decreasing dyspnea. Objective: To determine the physiological effect of HFTO compared to COT on sputum viscoelasticity, respiratory effort and dyspnoea. Study design: Pilot study with randomized crossover design, single-center. Study population: Twenty adult patients weaning from mechanical ventilation with tracheostomy. Intervention (if applicable): Crossover with COT and HFTO during two days in the weaning phase. Main study parameters/endpoints: Primary endpoint: sputum viscoelasticity measured by rheology during long disconnection sessions in the final phase of weaning. Secondary endpoints: respiratory effect measured by swings in esophageal pressure (PES) and prevalence and severity of dyspnoea sensation by visual analogue scale (VAS). Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The study compares two therapeutic modalities both used in clinical care without side-effects or complications. Study procedures and measurements consist of standard clinical procedures that are performed daily in clinical setting with negligible risk of deterioration for the patient. During weaning with HFTO sputum clearance might be more easy for the patient and respiratory effort might decrease, both are assumed to be beneficial for the weaning process of the patient.

CONDITIONS

Official Title

Physiological Effect High-flow Tracheal Oxygen on Viscosity of Airway Mucus and Respiratory Effort in Patients Weaning from Invasive Mechanical Ventilation

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Currently weaning from mechanical ventilation with a tracheostomy
Not Eligible

You will not qualify if you...

  • Longstanding tracheostomy present before current hospital admission
  • Tracheostomy primarily for chronic upper airway obstruction or airway patency due to persistent stupor/coma
  • Chronic positive pressure respiratory support at home (excluding night-time CPAP for sleep apnea)
  • History of mucociliary diseases such as cystic fibrosis or pulmonary ciliary dyskinesia
  • History of neuromuscular disease (excluding ICU-acquired weakness)
  • Contraindications for esophageal balloon placement including fractures in mandibular, orbital, ethmoid bone or skull base; esophageal varices or surgery; severe bleeding disorders
  • Hemoptysis in the 72 hours before the first disconnection session requiring intervention or pro-coagulating drugs like tranexamic acid

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Erasmus Medical Center

Rotterdam, Netherlands, 3015

Actively Recruiting

Loading map...

Research Team

T

Thijs Janssen Resident pulmonology, Critical Care researcher, MD

CONTACT

H

Henrik Endeman Intensivist, Assistant Professor Intensive Care, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here